( August 14, 2026, 16:16 GMT | Official Statement) -- MLex Summary: Drugmakers Vertex and Crinetics saw their US premerger waiting period expire Aug. 12, and as of Aug. 13, the companies had obtained approval for their deal from Germany, Austria and Australia, according to paperwork submitted to the US Securities and Exchange Commission. The Vertex-Crinetics merger is expected to close in early September, according to the SEC filing.See SEC filing excerpt below. ...
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.